Fibroblastic rheumatism

Response of Fibroblastic Rheumatism to Infliximab

Onset is usually sudden with symmetrical articular involvement of both small and large joints, occurrence of solid skin nodules, and rapid progression. Treatment is generally unrewarding. Here we report a severe and disabling case of FR responding favorably to infliximab therapy. After 32 weeks of continuous treatment, skin lesions dramatically improved and arthropathy partially regressed.

Fibroblastic rheumatism: a Scandinavian case report.

CASE REPORT A 55 year old Danish woman was referred to our department in July 2000 with a 2K year history of pain in the proximal interphalangeal (PIP) joints, knees, and ankles. The pain worsened over night and upon exercise. On examination, the right knee and the second PIP joint on the left hand were tender and swollen. The other PIP joints and both wrists were tender. On both hands there we...

Proliferation characteristics and polyploidization of cultured myofibroblasts from a patient with fibroblastic rheumatism.

Fibroblast-like cells were obtained from a nodule of a patient with fibroblastic rheumatism, and grown in culture for different times (from passage 3 to 21). These cells as well as the fibroblasts taken from an unaffected skin area (controls) of the same patient, have been investigated by fluorescence microscopy, cytochemical methods and cytometry, to evaluate their cytodifferentiation features...

Rheumatism

IT is natural that a (lisease of the social and econiomic importance of rheumatism should ocCIpy a considerable place in medical literature. Nevertheless, until the last few nears, little of importanice has been adide(d to ourikniowle(dge of this crippling group of dliseases. Significant advances in treatmenit, a closer stu(dy of the composition of synovial fluii(d and(l of the factors wvhich i...

Rheumatism